🍯 Spotify founders invest in longevity

AI will revolutionise the longevity field

Welcome, humans. This is Ambrosia Path, the newsletter that delivers you the latest longevity developments 📰

Longevity Headlines

  • Spotify founders invested in a Swedish longevity clinic, owning 50% 🎵

  • A new paper used generative AI to get a drug from target discovery to preclinical candidate in just 18 months (VERY QUICK) 🤖

  • Neurocode launched new blood test to diagnose Alzheimer’s 🩸

  • Drama in the longevity industry with Matt Kaeberlein accusing David Sinclair 😮

  • Many of us are walking around with at least one organ aging more quickly than others 🫀

  • Certain smells can accelerate mortality and aging 👃

  • Life expectancy growth in rich countries has stopped barring major advances in life extending technologies 📉

  • A visual guide on how longevity science looks to slow diseases of aging 🗺️

That’s it for longevity news today folks! Have a fantastic day!

Hot Tip: If this email landed in your promotions folder, move it to primary to make sure you see the next edition!

Disclaimer: This information does not constitute health and/or financial advice or a recommendation and should not be considered as such